PolyPid Introduces PD01B Candidate for Diabetic Foot Infections
PolyPid announced PD01B, a new Kynatrix-based product candidate for treating diabetic foot infections, as part of an expanded pipeline strategy.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
PolyPid announced PD01B, a new Kynatrix-based product candidate for treating diabetic foot infections, as part of an expanded pipeline strategy.